HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors
Clinical trial NCT02536469 · COMPLETED
Trial details
- NCT number
- NCT02536469
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2016-11-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.